Hot Pursuit     26-Apr-24
Biocon Ltd spurts 4.01%, rises for fifth straight session
Biocon Ltd is quoting at Rs 303.35, up 4.01% on the day as on 12:44 IST on the NSE. The stock is up 30.22% in last one year as compared to a 25.61% spurt in NIFTY and a 51.85% spurt in the Nifty Pharma.

Biocon Ltd gained for a fifth straight session today. The stock is quoting at Rs 303.35, up 4.01% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is down around 0.29% on the day, quoting at 22503.9. The Sensex is at 74098.62, down 0.32%. Biocon Ltd has risen around 18.22% in last one month.

Meanwhile, Nifty Pharma index of which Biocon Ltd is a constituent, has risen around 1.29% in last one month and is currently quoting at 18878.15, up 0.7% on the day. The volume in the stock stood at 212.7 lakh shares today, compared to the daily average of 69.52 lakh shares in last one month.

The benchmark May futures contract for the stock is quoting at Rs 305.4, up 3.61% on the day. Biocon Ltd is up 30.22% in last one year as compared to a 25.61% spurt in NIFTY and a 51.85% spurt in the Nifty Pharma index.

The PE of the stock is 0 based on TTM earnings ending December 23.

Previous News
  Stock Alert: Indegene, Wipro, Biocon, HUDCO
 ( Market Commentary - Stock Alert 13-May-24   08:28 )
  Biocon signs distribution and supply agreement with Medix
 ( Corporate News - 13-May-24   09:36 )
  Biocon appoints Interim CFO
 ( Corporate News - 11-Jun-24   17:16 )
  Biocon's subsidiary receives UK’s MHRA approval for Aflibercept biosimilar
 ( Hot Pursuit - 13-Nov-23   17:05 )
  Biocon Ltd spurts 1.53%
 ( Hot Pursuit - 05-Sep-23   13:05 )
  Biocon 's biologics subsidiary gets European Commission's nod for Aflibercept biosimilar
 ( Hot Pursuit - 21-Sep-23   09:24 )
  Biocon consolidated net profit rises 31.27% in the March 2023 quarter
 ( Results - Announcements 24-May-23   07:33 )
  Biocon gets US FDA nod for fungal infection drug
 ( Hot Pursuit - 04-Jun-24   11:18 )
  Biocon inks pact with Medix to commercialize weight mgmt product
 ( Hot Pursuit - 13-May-24   08:05 )
  Eris Lifesciences avails term loan of Rs 280 cr from Citi Bank
 ( Corporate News - 09-Nov-23   09:15 )
  Biocon's Hyderabad facility gets 3 USFDA observations
 ( Hot Pursuit - 22-Jul-22   08:34 )
Other Stories
  G.M. Breweries records 25% YoY rise in Q1 PAT
  09-Jul-24   16:34
  RPP Infra soars on bagging construction orders
  09-Jul-24   15:36
  Infibeam board OKs to acquire 26% stake in Infibeam Digital Ent
  09-Jul-24   15:14
  Maruti Suzuki spurts on UP Govt's hybrid car tax waiver
  09-Jul-24   15:12
  Ahluwalia Contracts (India) Ltd leads losers in 'A' group
  09-Jul-24   15:01
  Metropolis Healthcare revenue climbs 13% YoY Q1
  09-Jul-24   14:53
  Shubham Polyspin Ltd leads losers in 'B' group
  09-Jul-24   14:46
  Swan Energy sizzles as BlackRock buys stake
  09-Jul-24   14:45
  Volumes soar at Jubilant Ingrevia Ltd counter
  09-Jul-24   14:31
  Telecom shares fall
  09-Jul-24   14:01
Back Top